ValiRx (VAL) Competitors GBX 0.54 +0.00 (+0.37%) As of 04:31 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock VAL vs. HNR, NOG, SUN, WRES, EQT, CRC, WEB, NBL, FTO, and TXOShould you be buying ValiRx stock or one of its competitors? The main competitors of ValiRx include Highlands Natural Resources (HNR), Nostrum Oil & Gas (NOG), Surgical Innovations Group (SUN), W Resources (WRES), EQTEC (EQT), Circle Property (CRC), Webis (WEB), 18564 (NBL.L) (NBL), 2059984 (FTO.L) (FTO), and 282082 (TXO.L) (TXO). These companies are all part of the "petroleum and natural gas" industry. ValiRx vs. Its Competitors Highlands Natural Resources Nostrum Oil & Gas Surgical Innovations Group W Resources EQTEC Circle Property Webis 18564 (NBL.L) 2059984 (FTO.L) 282082 (TXO.L) Highlands Natural Resources (LON:HNR) and ValiRx (LON:VAL) are both small-cap petroleum and natural gas companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership. Does the media favor HNR or VAL? In the previous week, ValiRx had 2 more articles in the media than Highlands Natural Resources. MarketBeat recorded 2 mentions for ValiRx and 0 mentions for Highlands Natural Resources. Highlands Natural Resources' average media sentiment score of 0.00 beat ValiRx's score of -0.65 indicating that Highlands Natural Resources is being referred to more favorably in the media. Company Overall Sentiment Highlands Natural Resources Neutral ValiRx Negative Which has stronger earnings & valuation, HNR or VAL? Highlands Natural Resources has higher revenue and earnings than ValiRx. ValiRx is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHighlands Natural Resources£1.02M0.00N/A-£4.90N/AValiRx£49.78K40.61-£5.71M-£0.01-58.06 Is HNR or VAL more profitable? Highlands Natural Resources has a net margin of 0.00% compared to ValiRx's net margin of -20,554.01%. Highlands Natural Resources' return on equity of 0.00% beat ValiRx's return on equity.Company Net Margins Return on Equity Return on Assets Highlands Natural ResourcesN/A N/A N/A ValiRx -20,554.01%-55.84%-35.98% Do institutionals & insiders have more ownership in HNR or VAL? 35.4% of ValiRx shares are owned by institutional investors. 54.1% of ValiRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. SummaryHighlands Natural Resources beats ValiRx on 6 of the 10 factors compared between the two stocks. Get ValiRx News Delivered to You Automatically Sign up to receive the latest news and ratings for VAL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VAL vs. The Competition Export to ExcelMetricValiRxBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£2.02M£235.37M£6.11B£2.60BDividend Yield0.63%3.80%5.66%5.29%P/E Ratio-58.0696.0287.104,456.64Price / Sales40.616,233.13538.9299,689.02Price / Cash62.5013.1926.3027.90Price / Book0.20110.6812.698.21Net Income-£5.71M-£90.99M£3.30B£5.89B7 Day Performance-8.32%4.74%3.53%1.21%1 Month Performance-25.52%7.66%6.74%6.49%1 Year Performance-60.00%615.58%72.67%154.86% ValiRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VALValiRxN/AGBX 0.54+0.4%N/A-60.1%£2.02M£49.78K-58.065,450Earnings ReportGap DownHNRHighlands Natural ResourcesN/AN/AN/AN/A£6.95M£1.02M-0.9616Gap DownHigh Trading VolumeNOGNostrum Oil & Gas0.4737 of 5 starsGBX 3.88+9.9%GBX 4+3.1%-1.8%£6.40M£135.89M-2.8730Gap DownSUNSurgical Innovations GroupN/AGBX 0.57-0.7%N/A+3.8%£5.33M£11.95M-271.9080Gap UpWRESW ResourcesN/AN/AN/AN/A£3.89M£3.47M-0.4366Gap DownEQTEQTECN/AGBX 0.37-7.5%N/A-49.1%£2.37M£2.20M-5.44740Gap DownCRCCircle PropertyN/AN/AN/AN/A£1.02M£7.57M50.001,060Gap DownHigh Trading VolumeWEBWebisN/AN/AN/AN/A£157K£49.70M14.1350Gap DownNBL18564 (NBL.L)N/AN/AN/AN/A£0.00N/A0.002,330FTO2059984 (FTO.L)N/AN/AN/AN/A£0.00N/A0.00147,000TXO282082 (TXO.L)N/AN/AN/AN/A£0.00N/A0.00170 Related Companies and Tools Related Companies Highlands Natural Resources Alternatives Nostrum Oil & Gas Alternatives Surgical Innovations Group Alternatives W Resources Alternatives EQTEC Alternatives Circle Property Alternatives Webis Alternatives 18564 (NBL.L) Alternatives 2059984 (FTO.L) Alternatives 282082 (TXO.L) Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:VAL) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ValiRx plc Please log in to your account or sign up in order to add this asset to your watchlist. Share ValiRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
